Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release
复制标题
DOI:
10.1152/ajpheart.2000.279.6.h2865
复制
发表时间:
2000-12-01
影响因子:
4.8
通讯作者:
Rozdzinski, E
中科院分区:
文献类型:
--
作者:
Haug, C;Schmid-Kotsas, A;Rozdzinski, E
Low-density lipoproteins (LDL) are known to cause endothelial injury and to promote the development of atherosclerotic lesions. This study demonstrates a significant concentration-dependent stimulatory effect of LDL on hepatocyte growth factor (HGF) synthesis (maximum release: 423 +/- 16% of control) and HGF receptor mRNA expression in cultured human coronary artery endothelial cells (HCAEC). HGF is a potent mitogen for endothelial cells but does not affect smooth muscle cell proliferation. In contrast, endothelin-1 (ET-1) acts as a mitogen on vascular smooth muscle cells and seems to be upregulated in coronary atherosclerosis. In this study, the basal ET-1 synthesis in HCAEC was concentration-dependently reduced by HGF (minimum: 54 +/- 3% of control). This inhibitory effect seems to be mediated via the tyrosine kinase activity of the HGF receptor c-met, since it was antagonized by the tyrosine kinase inhibitor lavendustin A. In addition, HGF also significantly reduced the LDL-stimulated ET-1 release. The LDL-induced upregulation of HGF synthesis in HCAEC and the inhibitory effect of HGF on ET-1 synthesis suggest a protective role of HGF in coronary atherosclerosis.